Towards biomarker-based tests that can facilitate decisions about prevention and management of preeclampsia in low-resource settings (Q38493639)

3 September 2017

1 reference

title

Towards biomarker-based tests that can facilitate decisions about prevention and management of preeclampsia in low-resource settings (English)

1 reference

3 September 2017

0 references

0 references

6

Claudia M Harner-Jay

1 reference

3 September 2017

4

Tara M Herrick

1 reference

3 September 2017

Nathalie Acestor

1

1 reference

3 September 2017

Jane Goett

2

1 reference

3 September 2017

Arthur Lee

3

1 reference

3 September 2017

Susheela M Engelbrecht

5

1 reference

3 September 2017

Bonnie J Howell

7

1 reference

3 September 2017

Bernhard H Weigl

8

1 reference

3 September 2017

20 May 2015

1 reference

Clinical Chemistry and Laboratory Medicine

3 September 2017

1 reference

3 September 2017

54

1 reference

3 September 2017

17-27

1 reference

3 September 2017

1

1 reference

Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia.

3 September 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Serum markers in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Novel biomarkers for predicting preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Calcium supplementation and prevention of preeclampsia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

GRP78 as a marker of pre-eclampsia: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Could molecular assessment of calcium metabolism be a useful tool to early screen patients at risk for pre-eclampsia complicated pregnancy? Proposal and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Review: Biochemical markers to predict preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Recent advances in the understanding of the pathophysiology of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

The global impact of pre-eclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Circulating levels of copeptin, a novel biomarker in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Biomarkers in pre-eclampsia: a novel approach to early detection of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Serum levels of growth arrest specific protein 6 are increased in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

N-terminal pro-brain natriuretic Peptide as a biomarker for hypertensive disorders of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Random urine protein/creatinine ratio readily predicts proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

HtrA3 as an early marker for preeclampsia: specific monoclonal antibodies and sensitive high-throughput assays for serum screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

Field evaluation of a prototype paper-based point-of-care fingerstick transaminase test

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0069

21 January 2018

Identifiers

DOI

10.1515/CCLM-2015-0069

1 reference

3 September 2017

1 reference